and hopefully more; i am holding till december
This is dead money for quite some time at best until there is more clarity on ziop and intrexon...a long wait my friends
I think if Kirk moved in a few senior guys onto BOD and we see some good data in May on Melanoma this could turn.
Hopefully we get another 8-K soon. My gut is that Lewis stays on and fills the dual CEO/CSO role to conserve cash. No need for expensive NYC RE. Maybe they consolidate into MA or move operations to an Intrexon location.